Japan’s Nipro acquires Croatian glass vials and ampoules producer Piramida
- by croatiaweek
- in Business
(Photo: Piramida)
Piramida is currently among the five largest manufacturers of glass ampoules for the pharmaceutical industry in the European market
Croatian company Piramida, a manufacturer of glass packaging for the pharmaceutical industry, has been sold to Japan’s Nipro PharmaPackaging International.
Blue Sea Capital, a regional private equity fund which owned the Croatian company, and Nipro PharmaPackaging have closed the sale and transfer of full ownership stake in Piramida, Nipro said in a statement on Monday.
Established in 1950 and operating out of Sesvete near the Croatian capital Zagreb, Piramida last year produced more than half a billion ampoules and bottles for the pharmaceutical industry. The company is ranked among the top five largest ampoule manufacturers for the pharmaceutical industry in the European market.
Nipro PharmaPackaging is part of Nipro Corporation Japan, established in 1954. As a leading global healthcare company with over 33.000 employees worldwide, Nipro serves the Pharmaceutical, Medical Device, and Pharma Packaging Industries.
“The management team is looking forward to working with Nipro to further advance Piramida’s position on the European and global markets,” Kresimir Sečak, CEO of Piramida, said.
Saša Galić, Managing Partner of Blue Sea Capital, commented: “We are proud that Piramida has attracted the interest of one of the leading global players in the pharmaceutical packaging industry. We are excited to watch Piramida enter a new phase of growth with global ambitions.”
With an outstanding market position in the Central European Territory, alongside an impeccable reputation combined with sound and strong customer relationships, Piramida is a very important asset to Nipro’s future and its ambitious growth plans. Pharmaceutical glass packaging plays a crucial role in today’s challenging world, especially in the wake of the COVID-19 pandemic and the increased production of vaccines.
“We want to continue to build excellent customer relationships and become the preferred strategic partner to many pharmaceutical companies,” Stephan Arnold, CEO of Nipro PharmaPackaging International said.
